Current reports
8-K
Other Events
26 Apr 24
8-K
Other Events
20 Feb 24
8-K
FibroBiologics Presents Preclinical Data at the 2024 Keystone Symposia for Systemic Autoimmune and Autoinflammatory Diseases
13 Feb 24
8-K
FibroBiologics Announces Three United States Patents for Fibroblast Technology
8 Feb 24
8-K
FibroBiologics Announces Three Japanese Patents on Fibroblast Technology
6 Feb 24
8-K
FibroBiologics Announces Direct Listing on NASDAQ Under the Stock Ticker FBLG
1 Feb 24
Registration and prospectus
S-1
IPO registration
25 Apr 24
424B4
Prospectus supplement with pricing info
28 Mar 24
S-1/A
IPO registration (amended)
26 Mar 24
S-1/A
IPO registration (amended)
15 Mar 24
S-1
IPO registration
12 Feb 24
424B4
Prospectus supplement with pricing info
30 Jan 24
S-1/A
IPO registration (amended)
24 Jan 24
8-A12B
Registration of securities on exchange
24 Jan 24
S-1/A
IPO registration (amended)
24 Jan 24
S-1/A
IPO registration (amended)
22 Jan 24
Proxies
No filings
Other
EFFECT
Notice of effectiveness
29 Mar 24
CERT
Certification of approval for exchange listing
30 Jan 24
EFFECT
Notice of effectiveness
25 Jan 24
CORRESP
Correspondence with SEC
22 Jan 24
CORRESP
Correspondence with SEC
16 Jan 24
CORRESP
Correspondence with SEC
7 Nov 23
UPLOAD
Letter from SEC
27 Oct 23